Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

The role of self-awareness and cognitive dysfunction in Parkinson's disease with and without impulse-control disorder.

Mack J, Okai D, Brown RG, Askey-Jones S, Chaudhuri KR, Martin A, Samuel M, David AS.

J Neuropsychiatry Clin Neurosci. 2013 Spring;25(2):141-9. doi: 10.1176/appi.neuropsych.12030076.

PMID:
23686032
2.

Sociodemographic, neuropsychiatric and cognitive characteristics of pathological gambling and impulse control disorders NOS in Parkinson's disease.

Pontieri FE, Assogna F, Pellicano C, Cacciari C, Pannunzi S, Morrone A, Danese E, Caltagirone C, Spalletta G.

Eur Neuropsychopharmacol. 2015 Jan;25(1):69-76. doi: 10.1016/j.euroneuro.2014.11.006. Epub 2014 Nov 18.

PMID:
25435085
3.

Dopaminergic influences on executive function and impulsive behaviour in impulse control disorders in Parkinson's disease.

Leroi I, Barraclough M, McKie S, Hinvest N, Evans J, Elliott R, McDonald K.

J Neuropsychol. 2013 Sep;7(2):306-25. doi: 10.1111/jnp.12026. Epub 2013 Jul 31.

PMID:
23901888
4.

Predictors of discrepancies in Parkinson's disease patient and caregiver ratings of apathy, disinhibition, and executive dysfunction before and after diagnosis.

Schiehser DM, Liu L, Lessig SL, Song DD, Obtera KM, Burke Iii MM, Earl SR, Vincent Filoteo J.

J Int Neuropsychol Soc. 2013 Mar;19(3):295-304. doi: 10.1017/S1355617712001385. Epub 2013 Jan 28.

PMID:
23351239
5.

Awareness of executive deficits in people with Parkinson's disease.

Kudlicka A, Clare L, Hindle JV.

J Int Neuropsychol Soc. 2013 May;19(5):559-70. doi: 10.1017/S1355617713000064. Epub 2013 Feb 15.

PMID:
23410890
6.

Long-term cognitive follow-up of Parkinson's disease patients with impulse control disorders.

Siri C, Cilia R, Reali E, Pozzi B, Cereda E, Colombo A, Meucci N, Canesi M, Zecchinelli AL, Tesei S, Mariani CB, Sacilotto G, Zini M, Pezzoli G.

Mov Disord. 2015 Apr 15;30(5):696-704. doi: 10.1002/mds.26160. Epub 2015 Mar 11.

PMID:
25757654
7.

Neuropsychological features of patients with Parkinson's disease and impulse control disorders.

Bentivoglio AR, Baldonero E, Ricciardi L, De Nigris F, Daniele A.

Neurol Sci. 2013 Jul;34(7):1207-13. doi: 10.1007/s10072-012-1224-5. Epub 2012 Nov 18.

PMID:
23161255
8.

Awareness of expressivity deficits in non-demented Parkinson disease.

Mikos AE, Springer US, Nisenzon AN, Kellison IL, Fernandez HH, Okun MS, Bowers D.

Clin Neuropsychol. 2009 Jul;23(5):805-17. doi: 10.1080/13854040802572434. Epub 2009 Jan 26.

PMID:
19169938
9.

Assessing self-awareness of dyskinesias in Parkinson's disease through movie materials.

Sitek EJ, Soltan W, Wieczorek D, Robowski P, Schinwelski M, Slawek J.

Funct Neurol. 2011 Jul-Sep;26(3):121-6.

10.
11.

The relationship between specific cognitive defects and burden of care in Parkinson's disease.

Zhong M, Peppard R, Velakoulis D, Evans AH.

Int Psychogeriatr. 2016 Feb;28(2):275-81. doi: 10.1017/S1041610215001593. Epub 2015 Oct 5.

PMID:
26434985
12.

Impulse control and related disorders in Mexican Parkinson's disease patients.

Rodríguez-Violante M, González-Latapi P, Cervantes-Arriaga A, Camacho-Ordoñez A, Weintraub D.

Parkinsonism Relat Disord. 2014 Aug;20(8):907-10. doi: 10.1016/j.parkreldis.2014.05.014. Epub 2014 Jun 5.

PMID:
24935236
13.

Clinical and neuropsychological correlates of impaired awareness of deficits in Alzheimer disease and Parkinson disease: a comparative study.

Seltzer B, Vasterling JJ, Mathias CW, Brennan A.

Neuropsychiatry Neuropsychol Behav Neurol. 2001 Apr-Jun;14(2):122-9.

PMID:
11417666
14.

Clinical characteristics of impulse control and repetitive behavior disorders in Parkinson's disease.

Kim J, Kim M, Kwon DY, Seo WK, Kim JH, Baik JS, Koh SB.

J Neurol. 2013 Feb;260(2):429-37. doi: 10.1007/s00415-012-6645-9. Epub 2012 Aug 15.

PMID:
22893307
15.

Impulsive oculomotor action selection in Parkinson's disease.

Duprez J, Houvenaghel JF, Argaud S, Naudet F, Robert G, Drapier D, Vérin M, Sauleau P.

Neuropsychologia. 2017 Jan 27;95:250-258. doi: 10.1016/j.neuropsychologia.2016.12.027. Epub 2016 Dec 28.

16.

Medication management and neuropsychological performance in Parkinson's disease.

Manning KJ, Clarke C, Lorry A, Weintraub D, Wilkinson JR, Duda JE, Moberg PJ.

Clin Neuropsychol. 2012;26(1):45-58. doi: 10.1080/13854046.2011.639312. Epub 2011 Dec 12.

17.

Problematic Internet use in Parkinson's disease.

Wu K, Politis M, O'Sullivan SS, Lawrence AD, Warsi S, Lees A, Piccini P.

Parkinsonism Relat Disord. 2014 May;20(5):482-7. doi: 10.1016/j.parkreldis.2014.01.019. Epub 2014 Feb 5.

PMID:
24582704
18.

Single versus multiple impulse control disorders in Parkinson's disease: an ¹¹C-raclopride positron emission tomography study of reward cue-evoked striatal dopamine release.

Wu K, Politis M, O'Sullivan SS, Lawrence AD, Warsi S, Bose S, Lees AJ, Piccini P.

J Neurol. 2015 Jun;262(6):1504-14. doi: 10.1007/s00415-015-7722-7. Epub 2015 Apr 18.

PMID:
25893253
19.

Increased risk of impulse control symptoms in Parkinson's disease with REM sleep behaviour disorder.

Fantini ML, Macedo L, Zibetti M, Sarchioto M, Vidal T, Pereira B, Marques A, Debilly B, Derost P, Ulla M, Vitello N, Cicolin A, Lopiano L, Durif F.

J Neurol Neurosurg Psychiatry. 2015 Feb;86(2):174-9. doi: 10.1136/jnnp-2014-307904. Epub 2014 Jul 8.

20.

How well do caregivers detect mild cognitive change in Parkinson's disease?

Naismith SL, Pereira M, Shine JM, Lewis SJ.

Mov Disord. 2011 Jan;26(1):161-4. doi: 10.1002/mds.23331. Epub 2010 Sep 3.

PMID:
20818607

Supplemental Content

Support Center